S. Menon

851 total citations
16 papers, 621 citations indexed

About

S. Menon is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S. Menon has authored 16 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Rheumatology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S. Menon's work include Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). S. Menon is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). S. Menon collaborates with scholars based in United Kingdom, United States and Hungary. S. Menon's co-authors include David Isenberg, Jane G. Schaller, Lori B. Tucker, R.J.S. Chinn, Stanton Newman, Margaret Hall‐Craggs, M L Snaith, Zoé Kececioglu Draelos, Martin R. Hodge and Karen Page and has published in prestigious journals such as Annals of Oncology, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

S. Menon

14 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Menon United Kingdom 7 507 239 113 113 86 16 621
Natalia Soria Spain 5 474 0.9× 255 1.1× 90 0.8× 74 0.7× 87 1.0× 6 753
Sandra Muñoz Spain 6 428 0.8× 216 0.9× 88 0.8× 94 0.8× 109 1.3× 7 805
C. J. Edwards United Kingdom 9 416 0.8× 258 1.1× 48 0.4× 72 0.6× 73 0.8× 18 544
MT Bertero Italy 10 266 0.5× 142 0.6× 49 0.4× 108 1.0× 78 0.9× 14 517
Andrew R. Baldassare United States 12 402 0.8× 295 1.2× 220 1.9× 151 1.3× 206 2.4× 19 829
Michael P. Keith United States 10 396 0.8× 334 1.4× 107 0.9× 53 0.5× 87 1.0× 25 587
F. Houssiau Belgium 9 380 0.7× 173 0.7× 112 1.0× 37 0.3× 49 0.6× 11 472
Theo Dov Golan Israel 10 308 0.6× 189 0.8× 87 0.8× 62 0.5× 60 0.7× 13 460
Atsushi Fujisaku Japan 10 284 0.6× 172 0.7× 147 1.3× 104 0.9× 115 1.3× 24 480
Johann O. Schroeder Germany 12 332 0.7× 252 1.1× 122 1.1× 69 0.6× 62 0.7× 14 507

Countries citing papers authored by S. Menon

Since Specialization
Citations

This map shows the geographic impact of S. Menon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Menon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Menon more than expected).

Fields of papers citing papers by S. Menon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Menon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Menon. The network helps show where S. Menon may publish in the future.

Co-authorship network of co-authors of S. Menon

This figure shows the co-authorship network connecting the top 25 collaborators of S. Menon. A scholar is included among the top collaborators of S. Menon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Menon. S. Menon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Charles‐Schoeman, Christina, Maya H Buch, Deepak L. Bhatt, et al.. (2022). POS0674 RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE. Annals of the Rheumatic Diseases. 81. 611–612. 4 indexed citations
3.
Karpouzas, George, Zoltán Szekanecz, Eva Baecklund, et al.. (2022). POS0519 RELATIONSHIP BETWEEN DISEASE ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TOFACITINIB OR TNF INHIBITORS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE. Annals of the Rheumatic Diseases. 81. 517–518. 10 indexed citations
4.
Haifer, Craig, Ashish Srinivasan, S. Menon, et al.. (2019). Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study. Journal of Gastroenterology and Hepatology. 34. 155–156. 2 indexed citations
5.
Menon, S., et al.. (2018). First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK. Annals of Oncology. 29. x22–x22. 1 indexed citations
6.
Draelos, Zoé Kececioglu, David M. Pariser, Christopher Banfield, et al.. (2017). Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study. British Journal of Dermatology. 179(1). 54–62. 71 indexed citations
8.
Menon, S., et al.. (2008). A randomized, crossover study to determine bioequivalence of two brands of dexibuprofen 400 mg tablets in healthy Asian adult male subjects of Indian origin. International Journal of Clinical Pharmacology and Therapeutics. 46(1). 48–54. 1 indexed citations
9.
Krishnaswami, S., Stephen E. Steinberg, G Klintmalm, et al.. (2008). PHARMACOKINETIC PROFILE OF CP-690,550 IN DE NOVO RENAL ALLOGRAFT RECIPIENTS. Transplantation. 86(2S). 414–414. 3 indexed citations
10.
Menon, S., et al.. (1999). A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis & Rheumatism. 42(4). 735–741. 133 indexed citations
11.
Menon, S., C T Ravirajan, David A. Kandiah, et al.. (1997). The Production, Binding Characteristics and Sequence Analysis of Four Human IgG Monoclonal Antiphospholipid Antibodies. Journal of Autoimmunity. 10(1). 43–57. 33 indexed citations
12.
Menon, S. & David Isenberg. (1995). Rheumatological manifestations of haematological diseases.. Annals of the Rheumatic Diseases. 54(10). 787–795. 7 indexed citations
13.
Tucker, Lori B., S. Menon, Jane G. Schaller, & David Isenberg. (1995). ADULT- AND CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARISON OF ONSET, CLINICAL FEATURES, SEROLOGY, AND OUTCOME. Lara D. Veeken. 34(9). 866–872. 299 indexed citations
14.
Menon, S. & David Isenberg. (1995). Fetal calf serum in growth medium obscures the detection of early anticardiolipin antibody secreting clones. Journal of Immunological Methods. 186(1). 65–70. 3 indexed citations
15.
Menon, S. & Jo C. W. Edwards. (1994). MYCOTIC ARTHRITIS OF THE KNEE DUE TO MADURELLA GRISEA. Lara D. Veeken. 33(3). 292–295. 4 indexed citations
16.
Menon, S., M L Snaith, & David Isenberg. (1993). The Association of Malignancy with SLE: An Analysis of 150 Patients Long-Term Review. Lupus. 2(3). 177–181. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026